Huntington National Bank’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15 Hold
1
﹤0.01% 3575
2025
Q1
$15 Sell
1
-50
-98% -$750 ﹤0.01% 3602
2024
Q4
$675 Buy
51
+50
+5,000% +$662 ﹤0.01% 2453
2024
Q3
$14 Sell
1
-3,235
-100% -$45.3K ﹤0.01% 3621
2024
Q2
$41.9K Buy
3,236
+718
+29% +$9.29K ﹤0.01% 1185
2024
Q1
$35K Hold
2,518
﹤0.01% 1259
2023
Q4
$35.9K Sell
2,518
-388
-13% -$5.54K ﹤0.01% 1208
2023
Q3
$45K Buy
2,906
+334
+13% +$5.17K ﹤0.01% 1078
2023
Q2
$40.4K Buy
2,572
+54
+2% +$848 ﹤0.01% 1128
2023
Q1
$41.5K Sell
2,518
-1,341
-35% -$22.1K ﹤0.01% 1073
2022
Q4
$60.2K Buy
3,859
+1,023
+36% +$16K ﹤0.01% 928
2022
Q3
$37K Hold
2,836
﹤0.01% 1084
2022
Q2
$40K Sell
2,836
-1,290
-31% -$18.2K ﹤0.01% 1074
2022
Q1
$59K Buy
4,126
+1,290
+45% +$18.4K ﹤0.01% 1007
2021
Q4
$39K Buy
2,836
+1
+0% +$14 ﹤0.01% 1150
2021
Q3
$46K Sell
2,835
-441
-13% -$7.16K ﹤0.01% 1003
2021
Q2
$55K Buy
3,276
+759
+30% +$12.7K ﹤0.01% 923
2021
Q1
$46K Hold
2,517
﹤0.01% 883
2020
Q4
$46K Hold
2,517
﹤0.01% 842
2020
Q3
$45K Hold
2,517
﹤0.01% 821
2020
Q2
$45K Sell
2,517
-3,255
-56% -$58.2K ﹤0.01% 822
2020
Q1
$88K Sell
5,772
-655
-10% -$9.99K ﹤0.01% 622
2019
Q4
$126K Buy
6,427
+2,603
+68% +$51K ﹤0.01% 641
2019
Q3
$65K Sell
3,824
-2,483
-39% -$42.2K ﹤0.01% 760
2019
Q2
$112K Sell
6,307
-280
-4% -$4.97K ﹤0.01% 635
2019
Q1
$134K Buy
+6,587
New +$134K ﹤0.01% 607